Accordingly, this study quantified TIGIT and CD155 expression in CRC specimens and paired adjacent non-malignant mucosa, and examined how their expression relates to the examined major oncogenic mutations and MSI status. The gene discussed is PVR; the disease is colorectal carcinoma.